Nanjing King-Friend Biochemical Pharmaceutical Competitors and Similar CompaniesClear all
Nanjing King-Friend Biochemical Pharmaceutical's competitors and similar companies include UCB.
 Nanjing King-Friend Biochemical Pharmaceutical Nanjing King-Friend Biochemical Pharmaceutical (NKF, 南京健友生化制药股份有限公司) is a company that specializes in the research, production, and sales of medicines and health products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2000 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Nanjing, CN HQ Chengdu, CN Cork, IE Milano, IT Altrincham, GB Chicago, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 1,3606% decrease | Employees 9,052 |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) 34.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) ¥4b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods ¥2.4b (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit ¥1.5b (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ¥581.5m (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company